Related Experiment Video
Updated: Mar 5, 2026

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
Hormonal contraception: venous and arterial disease
1a Department of Gynaecology and Obstetrics , University of Udine , Udine , Italy.
Levonorgestrel (LNG)-based contraceptives are safer for venous thromboembolism (VTE) risk than newer options. However, biological data suggest they may be less favorable for arterial disease risk factors, particularly compared to drospirenone (DRSP).
Area of Science:
- Cardiovascular Health
- Pharmacology
- Epidemiology
Background:
- Hormonal contraceptives (HCs) have varying cardiovascular safety profiles.
- Levonorgestrel (LNG)-based HCs are widely used, but their cardiovascular safety relative to newer formulations requires evaluation.
Purpose of the Study:
- To assess the concordance between biological and epidemiological evidence on the cardiovascular safety of LNG-based HCs versus newer formulations.
- To evaluate risks for venous thromboembolism (VTE) and arterial diseases.
Main Methods:
- A narrative review of studies examining cardiovascular risk factors modified by different HCs.
- Analysis of concordance between biological data and epidemiological findings.
Main Results:
- General concordance exists for VTE risk, with LNG-based HCs showing lower risk than most newer formulations.
- Evidence for drospirenone (DRSP)-containing HCs is conflicting.
- LNG-based HCs appear less favorable than non-androgenic progestin HCs (especially DRSP) for arterial event risk factors.
Conclusions:
- Epidemiological data on arterial disease are limited by time lags, hindering reliable cardiovascular risk assessment.
- LNG-based HCs are safer for VTE risk but potentially less favorable for arterial risk factors compared to newer options like DRSP-containing HCs.
- Individual long-term safety considerations should include modifications in arterial risk factors.
Related Concept Videos
Venous Thrombosis I: Introduction
Birth Control Methods
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Venous Thrombosis III: Interprofessional Care
Varicose Veins I: Introduction

